NCT05432232View on ClinicalTrials.gov

The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

December 28, 2024

Study Completion Date

June 6, 2025

Conditions
Renal CancerTumor, SolidKidney CancerTumorTumor, BenignKidney Neoplasms
Interventions
DEVICE

HistoSonics Investigational System

The HistoSonics Investigational System is intended for the non-invasive destruction of kidney tissue using histotripsy, a non-thermal mechanical process of focused ultrasound.

Trial Locations (1)

LS9 7TF

Leeds Teaching Hospitals NHS Trust, Leeds

Sponsors

Lead Sponsor

HistoSonics, Inc.
All Listed Sponsors
lead

HistoSonics, Inc.

INDUSTRY

NCT05432232 - The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy | Biotech Hunter | Biotech Hunter